Urologic Subspecialties

Patient speaking with doctor

Our expert team of urologic subspecialists, offer comprehensive care and focus on a broad spectrum of non-cancerous conditions that effect the urinary system. Among the conditions treated include urinary stone disease, cystinuria, pelvic organ prolapse, prostate enlargement, traumatic injuries to the genitals and urinary tract, gender-affirming surgery, erectile dysfunction, male fertility, urinary incontinence and voiding dysfunction. Each day through leadership and compassion, these urologists bring excellence to urologic care with breakthrough research and innovative treatments that include minimally invasive procedures like Holmium laser enucleation (HoLEP) for benign prostatic hyperplasia (BPH); robotic and laparoscopic surgery for ureteral reconstruction; advanced robotic surgery for pelvic organ prolapse and urinary incontinence; medical management of neurogenic bladder and are the only program in Northern California that provides complete ultrasound-guided, radiation free treatment for complex urinary stones, a safer and more effective approach than x-ray based treatments.

UROLOGIC SUBSPECIALTY CLINICS

  • Kidney stones and urinary stone disease
  • Female bladder and pelvic health
  • Male sexual and reproductive health
  • Urologic trauma and recontruction
  • Lifetime congenital urology program (L-CUP)
  • Gender-affirming surgery
  • Benign prostatic hyperplasia

 

 

Urologic Subspecialties News & Highlights

Anne M. Suskind, MD, discusses the study, “Comparative outcomes for older adults undergoing surgery for bladder and bowel dysfunction.” Suskind is an associate professor of Urology and Obstetrics,...
Micha Yin-Zheng Cheng, MD, MPH, MS, a resident in the University of California San Francisco (UCSF) Department of Urology, discusses the challenge of improving diversity in the urology workforce....
In this video Micha Yin-Zheng Cheng, MD, MPH, MS, a resident in the University of California San Francisco (UCSF) Department of Urology discusses the background of the UCSF UReTER (UnderRepresented...
The California Institute for Regenerative Medicine (CIRM) approved investing more than $3.8 million in a Phase 1 clinical trial to create a stem cell-based therapy for urethral stricture disease led...
This past June the Dept. Urology celebrated the Emil A. Tanagho Visiting Professor and the graduating residents. Here are some highlights from the event. The Emil A. Tanagho Visiting Professor, Dr....
The Department of Urology recently celebrated Drs. Overland, Lindsey and Yang take the next step in their Urologic careers as well-respected 2022 graduates of the UCSF Urology Residency program. ...